Related Experiment Videos
Studies on WF-3161, a new antitumor antibiotic
The Journal of Antibiotics
|May 1, 1983
Summary
WF-3161, an antitumor antibiotic from Petriella guttulata, is a cyclic tetrapeptide. This novel compound effectively inhibited fungal growth and demonstrated significant therapeutic potential against leukemia in mice.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Pharmacology
Background:
- WF-3161 is an antitumor antibiotic identified from the fungus Petriella guttulata.
- Antitumor antibiotics are crucial in cancer chemotherapy and infectious disease treatment.
Purpose of the Study:
- To isolate and characterize the novel antitumor antibiotic WF-3161.
- To evaluate the biological activity of WF-3161 against fungal pathogens and leukemia models.
Main Methods:
- Antibiotic purification using solvent extraction and silica gel/reverse phase column chromatography.
- Chemical structure elucidation of WF-3161 (C31H44N4O6).
- In vitro antifungal activity testing against Trichophyton asteroides.
- In vivo efficacy assessment in mice bearing P-388 leukemia.
Main Results:
- WF-3161 was successfully purified and its cyclic tetrapeptide structure determined.
- The antibiotic comprises phenylalanine, leucine, pipecolinic acid, and 2-amino-8-oxo-9,10-epoxydecanoic acid.
- WF-3161 exhibited inhibitory effects on Trichophyton asteroides growth.
- Significant prolongation of survival was observed in mice with P-388 leukemia, indicating a high therapeutic index.
Conclusions:
- WF-3161 is a potent antitumor antibiotic with a unique cyclic tetrapeptide structure.
- The compound shows promise for treating fungal infections and certain types of leukemia.
- Further investigation into WF-3161's therapeutic applications is warranted.